Home Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
Article
Licensed
Unlicensed Requires Authentication

Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome

  • Vesna Dimitrijevic-Sreckovic , Emina Colak , Predrag Djordjevic , Drasko Gostiljac , Branko Sreckovic , Srdjan Popovic , Fadil Canovic , Miroljub Ilic , Radmila Obrenovic , Vladan Vukcevic , Dragan Nikolic , Tanja Nisic , Gordana Milic and Gordana Pejcic
Published/Copyright: September 11, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 9

Abstract

Background: The aim of this study was to examine prothrombogenic factors and antioxidative defense in obese children and adolescents with pre-metabolic and metabolic syndrome, and to analyze insulin secretion and resistance, early glycoregulation disorders and lipid status.

Methods: Insulin sensitivity was determined using the homeostasis model assessment for insulin resistance (HOMA-IR), while insulin secretion was determined using the homeostasis model assessment β (HOMA-β). Prothrombogenic factors analyzed were plasma plasminogen activator inhibitor-1 (PAI-1) and fibrinogen. Superoxide dismutase and glutathione peroxidase were measured as markers of antioxidative defense.

Results: Patients with metabolic syndrome were characterized with increased body mass index (BMI), waist circumference, and HOMA-IR and HOMA-β levels, and all had increased blood pressure and triglyceride levels, low high-density lipoprotein cholesterol levels, increased PAI-1 levels and reduced antioxidative defense levels. Patients with pre-metabolic syndrome had higher levels of basal and mean insulinemia during an oral glucose tolerance test, higher levels of HOMA-β and lower levels of antioxidative defense compared to patients with metabolic syndrome.

Conclusions: Negative correlations between antioxidative defense parameters and BMI, abdominal obesity, insulin secretion, systolic blood pressure and atherogenic lipid factors, as well as correlations between PAI-1 and insulin resistance and basal glycemia in the metabolic syndrome group contribute to accelerated atherosclerosis. Positive correlations between PAI-1 and waist circumference and BMI, and negative correlations between BMI and antioxidative defense in the pre-metabolic syndrome patients show that this early stage preceding the metabolic syndrome is also characterized by atherosclerotic complication risks and evident hyperinsulinism and insulin resistance.

Clin Chem Lab Med 2007;45:1140–4.


Corresponding author: Vesna Dimitrijevic-Sreckovic, MD, PhD, Associated Professor, Krupanjska 24, 11000 Belgrade, Serbia Phone: +381-64-2028571, Fax: +381-11-2685357,

Received: 2006-11-1
Accepted: 2007-3-21
Published Online: 2007-09-11
Published in Print: 2007-09-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. SIBioC 2007, 39th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Palacongressi Rimini (Italy), 2-5 October 2007
  2. Third “Biologie Prospective” Santorini Conference
  3. Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease
  4. Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients
  5. Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)
  6. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
  7. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
  8. Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
  9. Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
  10. Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems
  11. New perspectives and strategy research biomarkers for hepatocellular carcinoma
  12. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review
  13. The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
  14. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
  15. Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
  16. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
  17. Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
  18. The association between lipid profiles and breast cancer among Taiwanese women
  19. Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
  20. Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
  21. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
  22. Intra-individual variation in creatinine and cystatin C
  23. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention
  24. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination
  25. Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting
  26. Type B natriuretic peptide stability in frozen plasma
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.259/html
Scroll to top button